Polymyalgia rheumatica and giant cell arteritis: An in-depth look at diagnosis and treatment

被引:3
作者
Kennedy, Sally [1 ]
机构
[1] Med Univ S Carolina, Coll Nursing, Charleston, SC 29425 USA
来源
JOURNAL OF THE AMERICAN ACADEMY OF NURSE PRACTITIONERS | 2012年 / 24卷 / 05期
关键词
Vasculitis; rheumatology; disease; elderly; BIOPSY; EPIDEMIOLOGY; GUIDELINES; CRITERIA; PATIENT; FEVER; RISK;
D O I
10.1111/j.1745-7599.2012.00717.x
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Purpose: To provide an in-depth synthesis of the literature on polymyalgia rheumatic (PMR) and giant cell arteritis (GCA) that will assist the primary care nurse practitioner (NP) in recognizing the variety of symptom presentations, accurately evaluating laboratory data, developing a plan of care that includes current treatment guidelines, and adroitly managing patients for improved outcomes. Data sources: A thorough search of the literature was conducted including MEDLINE, CIHAHL, and PubMed encompassing the decades from the 1970s to the present. Conclusions: Because of the varied and vague symptom presentations of PMR and GCA, primary healthcare providers often misdiagnose these pathologies, delaying treatment and relief of suffering. Textbooks descriptions often omit supplemental content necessary to understand the intricacies of the presenting symptoms, diagnostic tests needed for work-up, and specific treatment for these overlapping pathologies. Implications for practice: Because PMR and GCA often present in the primary care setting, NPs must maintain a high index of suspicion when a patient over 60 years of age presents with vague complaints such as headache, weakness, anorexia, and malaise. Arriving at an accurate diagnosis in a timely fashion will lead to appropriate treatment and minimize patient suffering.
引用
收藏
页码:277 / 285
页数:9
相关论文
共 47 条
  • [1] HOW DOES PREVIOUS CORTICOSTEROID TREATMENT AFFECT THE BIOPSY FINDINGS IN GIANT-CELL (TEMPORAL) ARTERITIS
    ACHKAR, AA
    LIE, JT
    HUNDER, GG
    OFALLON, WM
    GABRIEL, SE
    [J]. ANNALS OF INTERNAL MEDICINE, 1994, 120 (12) : 987 - 992
  • [2] A comparison of the sensitivity of diagnostic criteria for polymyalgia rheumatica
    Bird, HA
    Leeb, BF
    Montecucco, CM
    Misiuniene, N
    Nesher, G
    Pai, S
    Pease, C
    Rovensky, J
    Rozman, B
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (04) : 626 - 629
  • [3] Are polymyalgia rheumatica and giant cell arteritis the same disease?
    Cantini, F
    Niccoli, L
    Storri, L
    Nannini, C
    Olivieri, I
    Padula, A
    Boiardi, L
    Salvarani, C
    [J]. SEMINARS IN ARTHRITIS AND RHEUMATISM, 2004, 33 (05) : 294 - 301
  • [4] Diagnosis and treatment of giant cell arteritis
    Cantini, Fabrizio
    Niccoli, Laura
    Nannini, Carlotta
    Bertoni, Michele
    Salvarani, Carlo
    [J]. DRUGS & AGING, 2008, 25 (04) : 281 - 297
  • [5] Capobianco D J., 2003, Adv Stud Med, V3, pS556
  • [6] The C-reactive protein
    Clyne, B
    Olshaker, JS
    [J]. JOURNAL OF EMERGENCY MEDICINE, 1999, 17 (06) : 1019 - 1025
  • [7] Agreement between Erythrocyte Sedimentation Rate and C-Reactive Protein in Hospital Practice
    Colombet, Isabelle
    Pouchot, Jacques
    Kronz, Vladimir
    Hanras, Xavier
    Capron, Loic
    Durieux, Pierre
    Wyplosz, Benjamin
    [J]. AMERICAN JOURNAL OF MEDICINE, 2010, 123 (09) : 863.e7 - 863.e13
  • [8] Dasgupta B, 2007, CLIN EXP RHEUMATOL, V25, pS130
  • [9] Giant cell arteritis - Disease patterns of clinical presentation in a series of 240 patients
    Gonzalez-Gay, MA
    Barros, S
    Lopez-Diaz, MJ
    Garcia-Porrua, C
    Sanchez-Andrade, A
    Llorca, J
    [J]. MEDICINE, 2005, 84 (05) : 269 - 276
  • [10] Giant cell arteritis and polymyalgia rheumatica: Two different but often overlapping conditions
    Gonzalez-Gay, MA
    [J]. SEMINARS IN ARTHRITIS AND RHEUMATISM, 2004, 33 (05) : 289 - 293